LARIMAR THERAPEUTICS, INC. Long-Term Debt, Maturity, Remainder of Fiscal Year
LARIMAR THERAPEUTICS, INC. (LRMR) had Long-Term Debt, Maturity, Remainder of Fiscal Year of $1.82 million as of 2019-09-30, per its 10-Q filed 2019-11-06.
Discontinued › Notes › Commitment and Contingencies
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear · last filed 2019-11-06
- 2019-09-30: Long-Term Debt, Maturity, Remainder of Fiscal Year $1.82M.
- 2019-06-30: Long-Term Debt, Maturity, Remainder of Fiscal Year $3.64M.
- 2019-03-31: Long-Term Debt, Maturity, Remainder of Fiscal Year $5.46M.
- 2018-09-30: Long-Term Debt, Maturity, Remainder of Fiscal Year $0.00.
| Period end | Long-Term Debt, Maturity, Remainder of Fiscal Year |
|---|---|
| 2019-09-30 | $1.82M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $3.64M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $5.46M 10-Q · filed 2019-05-09 |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-09 |
| 2018-06-30 | $0.00 10-Q · filed 2018-08-09 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-10 |
| 2016-09-30 | $756.00K 10-Q · filed 2016-11-09 |
| 2016-06-30 | $1.50M 10-Q · filed 2016-08-05 |
| 2016-03-31 | $2.22M 10-Q · filed 2016-05-10 |
| 2015-09-30 | $697.00K 10-Q · filed 2015-11-13 |
| 2015-06-30 | $1.38M 10-Q · filed 2015-08-14 |
| 2015-03-31 | $1.38M 10-Q · filed 2015-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |